| Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 344 | 2021 |
| Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease F Kanwal, JH Shubrook, LA Adams, K Pfotenhauer, VWS Wong, E Wright, ... Gastroenterology 161 (5), 1657-1669, 2021 | 285 | 2021 |
| Cutaneous manifestations of diabetes mellitus M Duff, O Demidova, S Blackburn, J Shubrook Clinical Diabetes 33 (1), 40-48, 2015 | 196 | 2015 |
| A machine learning approach to predicting blood glucose levels for diabetes management K Plis, R Bunescu, C Marling, J Shubrook, F Schwartz Workshops at the Twenty-Eighth AAAI conference on artificial intelligence, 2014 | 191 | 2014 |
| Vitamin D deficiency, its role in health and disease, and current supplementation recommendations KM Pfotenhauer, JH Shubrook Journal of Osteopathic Medicine 117 (5), 301-305, 2017 | 158 | 2017 |
| Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes JJ Chamberlain, WH Herman, S Leal, AS Rhinehart, JH Shubrook, ... Annals of internal medicine 166 (8), 572-578, 2017 | 153 | 2017 |
| Hypoglycemia in type 2 diabetes-more common than you think: a continuous glucose monitoring study RR Gehlaut, GY Dogbey, FL Schwartz, CR Marling, JH Shubrook Journal of diabetes science and technology 9 (5), 999-1005, 2015 | 151 | 2015 |
| Preparing for the NASH epidemic: a call to action F Kanwal, JH Shubrook, Z Younossi, Y Natarajan, E Bugianesi, ... Metabolism 122, 154822, 2021 | 143 | 2021 |
| Standards of medical care in diabetes—2022 abridged for primary care providers H Feldman, NAE Sayed, RS Freeman, RG McCoy, JA Moverley, SM Oser, ... Clinical Diabetes 40 (1), 10-38, 2022 | 134 | 2022 |
| Blood glucose level prediction using physiological models and support vector regression R Bunescu, N Struble, C Marling, J Shubrook, F Schwartz 2013 12th International Conference on Machine Learning and Applications 1 …, 2013 | 121 | 2013 |
| Pharmacologic approaches to glycemic treatment of type 2 diabetes: synopsis of the 2020 American diabetes association's standards of medical care in diabetes clinical guideline K Doyle-Delgado, JJ Chamberlain, JH Shubrook, N Skolnik, J Trujillo Annals of internal medicine 173 (10), 813-821, 2020 | 103 | 2020 |
| Cardiovascular disease and risk management: review of the American Diabetes Association Standards of Medical Care in Diabetes 2018 JJ Chamberlain, EL Johnson, S Leal, AS Rhinehart, JH Shubrook, ... Annals of internal medicine 168 (9), 640-650, 2018 | 103 | 2018 |
| Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications C Wysham, J Shubrook Postgraduate medicine 132 (8), 676-686, 2020 | 102 | 2020 |
| Common types of supraventricular tachycardia: diagnosis and management RA Colucci, MJ Silver, J Shubrook Am Fam Physician 82 (8), 942-52, 2010 | 100 | 2010 |
| Characterizing blood glucose variability using new metrics with continuous glucose monitoring data CR Marling, JH Shubrook, SJ Vernier, MT Wiley, FL Schwartz Journal of Diabetes Science and Technology 5 (4), 871-878, 2011 | 92 | 2011 |
| Empagliflozin in the treatment of type 2 diabetes: evidence to date JH Shubrook, BB Bokaie, SE Adkins Drug design, development and therapy, 5793-5803, 2015 | 91 | 2015 |
| Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and cognitive behavioral therapy M de Groot, T Doyle, M Kushnick, J Shubrook, J Merrill, E Rabideau, ... Current diabetes reports 12, 157-166, 2012 | 91 | 2012 |
| Experiences of children and adolescents with type 1 diabetes in school: survey of children, parents, and schools FL Schwartz, S Denham, V Heh, A Wapner, J Shubrook Diabetes Spectrum 23 (1), 47-55, 2010 | 87 | 2010 |
| Depression among adults with diabetes: prevalence, impact, and treatment options M de Groot, M Kushnick, T Doyle, J Merrill, M McGlynn, J Shubrook, ... Diabetes Spectrum 23 (1), 15-18, 2010 | 83 | 2010 |
| Treatment of type 1 diabetes: synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes JJ Chamberlain, RR Kalyani, S Leal, AS Rhinehart, JH Shubrook, ... Annals of Internal Medicine 167 (7), 493-498, 2017 | 81 | 2017 |
